Nrf2 is highly expressed in papillary thyroid cancer (PTC) and is associated with negative outcomes.
Research has indicated that Berberine (BBR) can lower Nrf2 levels and trigger apoptosis in cancer cells.
However, the exact molecular mechanisms behind its anticancer effects in PTC are not fully understood.
